RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Loyda Meléndez to Cannabinoids

Back to Details
This is a "connection" page, showing publications Loyda Meléndez has written about Cannabinoids.
Loyda Meléndez
Connection Strength
1.487
Cannabinoids
  1. Rosario-Rodr?guez LJ, Cantres-Rosario YM, Carrasquillo-Carri?n K, Rodr?guez-De Jes?s AE, Cartagena-Isern LJ, Garc?a-Requena LA, Roche-Lima A, Mel?ndez LM. Quantitative Proteomics Reveal That CB2R Agonist JWH-133 Downregulates NF-?B Activation, Oxidative Stress, and Lysosomal Exocytosis from HIV-Infected Macrophages. Int J Mol Sci. 2024 Mar 13; 25(6).
    View in: PubMed
    Score: 0.800
  2. Rosario-Rodr?guez LJ, Gerena Y, Garc?a-Requena LA, Cartagena-Isern LJ, Cuadrado-Ruiz JC, Borges-V?lez G, Mel?ndez LM. Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages. Sci Rep. 2022 01 07; 12(1):233.
    View in: PubMed
    Score: 0.687
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support